Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Chinese Medical Journal|September 14, 2022
Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancersShuoshuo Ma, Wenjing Wang, Dengyong Zhang, et al.Bioengineered|April 26, 2022
High expression of H2A histone family member Y promotes the proliferation and autophagy of hepatocellular carcinoma cellsJiasheng Lei, Shuoshuo Ma, Wanliang Sun, et al.Seminars in Cancer Biology|February 28, 2025
Immunosenescence and immunotherapy in elderly patients with hepatocellular carcinomaDengyong Zhang, Yan Zhu, Zhengchao Shen, et al.Medicine|August 10, 2022
A retrospective study on the clinical and pathological features of hepatic sarcomatoid carcinoma: Fourteen cases of a rare tumorShuoshuo Ma, Chunshuang Li, Yang Ma, et al.Journal of Advanced Research|September 12, 2025
Epigenetic orchestration of cancer-immune dynamics: mechanisms, technologies, and clinical advancementsYuanjun Lu, Shuoshuo Ma, Yau-Tuen Chan, et al.Frontiers in Surgery|January 23, 2023
Gastric infiltration of hepatic sarcomatoid carcinoma: A case report and literature reviewShuoshuo Ma, Dengyong Zhang, Guanru Zhao, et al.Frontiers in Immunology|May 11, 2026
Hepatitis B virus infection and outcomes of TACE plus lenvatinib and PD-1 inhibitor therapy in unresectable hepatocellular carcinoma: a real-world propensity score-matched studyYuhao Su, Yuxin Liang, Deyuan Zhong, et al.Heliyon|March 11, 2024
MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5Shuoshuo Ma, Fangfang Chen, Chuanle Lin, et al.Pharmaceuticals (Basel, Switzerland)|March 28, 2026
From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver FibrosisYingying Qin, Shuoshuo Ma, Haoyuan Hong, et al.BMC Cancer|January 22, 2026
Integrative multi-omics reveal a CD4⁺ T cell-derived six-gene signature linking the immune-stromal ecosystem to prognosis and immunotherapy selection in pancreatic cancerYuxin Liang, Shuoshuo Ma, Xing Chen, et al.Pageof 2